[144] Ametek, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for AMETEK, Inc. (AME) reports a proposed sale of 7,867 common shares through Charles Schwab & Co., Inc., with an aggregate market value of $1,479,209.00 and approximately 230,953,960 shares outstanding. The proposed approximate sale date is 09/11/2025 on the NYSE.

The shares were acquired on 02/22/2024 as equity compensation (RSU/PSU) from AMETEK, Inc. The filer states there were no securities sold in the past three months for the account and includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale filing; modest position relative to outstanding shares and no recent disposals reported.

This Form 144 notifies the market of a proposed sale of 7,867 common shares acquired 02/22/2024 as RSU/PSU, to be executed via Charles Schwab on the NYSE around 09/11/2025. The aggregate market value is stated as $1,479,209.00 against ~230.95 million shares outstanding, indicating this specific sale is small relative to total float. The filing contains the standard seller representations and reports no sales in the prior three months.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure consistent with Rule 144; no governance concerns evident from the filing alone.

The notice documents an insider's planned disposition of equity compensation under Rule 144 and includes the required attestations regarding material non-public information. There is no indication of unusual timing, additional related-party transactions, or concurrent disposals; based solely on this filing, there are no apparent governance red flags.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	7867	1479209.00	230953960	09/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/22/2024	RSU / PSU - see remarks	AMETEK, Inc.			7867	02/22/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AME Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 7,867 common shares via Charles Schwab with an aggregate market value of $1,479,209.00, to be sold approximately on 09/11/2025 on the NYSE.

When and how were the shares being sold acquired?

The shares were acquired on 02/22/2024 as equity compensation (RSU/PSU) from AMETEK, Inc.

Does the Form 144 report prior sales in the last three months?

No. The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Through which broker will the AME shares be sold?

The named broker is Charles Schwab & Co., Inc. located at 3000 Schwab Way, Westlake, TX 76262.

How large is this proposed sale relative to AMETEK's outstanding shares?

The filing lists 230,953,960 shares outstanding; the proposed sale of 7,867 shares represents a very small fraction of that total as stated in the document.

Does the filer claim any undisclosed material information about AME?

By signing the notice, the filer represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.